EP1096021A3 - Melanine mit verbesserten HIV replikationshemmenden Eigenschaften - Google Patents

Melanine mit verbesserten HIV replikationshemmenden Eigenschaften Download PDF

Info

Publication number
EP1096021A3
EP1096021A3 EP01102344A EP01102344A EP1096021A3 EP 1096021 A3 EP1096021 A3 EP 1096021A3 EP 01102344 A EP01102344 A EP 01102344A EP 01102344 A EP01102344 A EP 01102344A EP 1096021 A3 EP1096021 A3 EP 1096021A3
Authority
EP
European Patent Office
Prior art keywords
melanins
hiv replication
improved ability
inhibit hiv
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01102344A
Other languages
English (en)
French (fr)
Other versions
EP1096021A2 (de
Inventor
Stephen J. Garger, Jr.
Saul L. Neidleman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Large Scale Biology Corp
Original Assignee
Large Scale Biology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Large Scale Biology Corp filed Critical Large Scale Biology Corp
Publication of EP1096021A2 publication Critical patent/EP1096021A2/de
Publication of EP1096021A3 publication Critical patent/EP1096021A3/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP01102344A 1997-02-06 1998-02-04 Melanine mit verbesserten HIV replikationshemmenden Eigenschaften Withdrawn EP1096021A3 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US796822 1997-02-06
US08/796,822 US6300057B1 (en) 1997-02-06 1997-02-06 Melanins with improved ability to inhibit HIV replication
EP98904832A EP1014964A1 (de) 1997-02-06 1998-02-04 Melanine mit verbesserten hiv replicationshemmenden eigenschaften

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
EP98904832A Division EP1014964A1 (de) 1997-02-06 1998-02-04 Melanine mit verbesserten hiv replicationshemmenden eigenschaften

Publications (2)

Publication Number Publication Date
EP1096021A2 EP1096021A2 (de) 2001-05-02
EP1096021A3 true EP1096021A3 (de) 2004-03-10

Family

ID=25169150

Family Applications (3)

Application Number Title Priority Date Filing Date
EP98904832A Ceased EP1014964A1 (de) 1997-02-06 1998-02-04 Melanine mit verbesserten hiv replicationshemmenden eigenschaften
EP01102344A Withdrawn EP1096021A3 (de) 1997-02-06 1998-02-04 Melanine mit verbesserten HIV replikationshemmenden Eigenschaften
EP01102345A Withdrawn EP1095652A3 (de) 1997-02-06 1998-02-04 Melanine mit verbesserten HIV replikationshemmenden Eigenschaften

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP98904832A Ceased EP1014964A1 (de) 1997-02-06 1998-02-04 Melanine mit verbesserten hiv replicationshemmenden eigenschaften

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP01102345A Withdrawn EP1095652A3 (de) 1997-02-06 1998-02-04 Melanine mit verbesserten HIV replikationshemmenden Eigenschaften

Country Status (9)

Country Link
US (2) US6300057B1 (de)
EP (3) EP1014964A1 (de)
JP (1) JP2001512437A (de)
KR (1) KR20000070851A (de)
AU (1) AU730073B2 (de)
CA (1) CA2280178A1 (de)
IL (1) IL131233A0 (de)
WO (1) WO1998034606A1 (de)
ZA (1) ZA98975B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6300057B1 (en) * 1997-02-06 2001-10-09 Large Scale Biology Corporation Melanins with improved ability to inhibit HIV replication
CA2522088A1 (en) * 2003-04-16 2004-11-04 The University Of Mississippi Immunostimulatory agents in botanicals
JP4677601B2 (ja) * 2004-09-30 2011-04-27 泰広 飯田 フローインジェクション分析装置およびフローインジェクション分析方法
US8586090B2 (en) * 2004-10-05 2013-11-19 Albert Einstein College Of Medicine Of Yeshiva University Melanin nanoshells for protection against radiation and electronic pulses
US8673983B2 (en) * 2007-12-21 2014-03-18 Loyola University Chicago Melanins synthesized chemically or via enzyme catalysis
EP2474313A1 (de) 2011-01-11 2012-07-11 ABRA Pharmaceuticals sàrl Neue, selbstanordnende polyphenolchinoide Polymerderivate und deren Verwendung

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990012869A1 (en) * 1989-04-26 1990-11-01 Sloan-Kettering Institute For Cancer Research Non-melanocytic, eucaryotic cell constitutively expressing biologically active human tyrosinase and use thereof
WO1992000373A1 (en) * 1990-06-29 1992-01-09 Biosource Genetics Corporation Melanin production by transformed microorganisms
WO1992016189A1 (en) * 1990-10-25 1992-10-01 Yale University Soluble melanin
US5340734A (en) * 1992-11-25 1994-08-23 Biosource Genetics Corporation Method for making stable, extracellular tyrosinase and synthesis of polyphenolic polymers therefrom
US5529909A (en) * 1988-02-26 1996-06-25 Biosource Technologies, Inc. Tyrosinase-activator protein fusion enzyme

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057325A (en) * 1990-03-20 1991-10-15 Vanderbilt University Method of inhibiting replication of HIV with water-soluble melanins
US5157075A (en) 1990-05-02 1992-10-20 Taenaka Mining Co., Ltd. Modified melanin
KR0184014B1 (ko) 1990-05-14 1999-05-01 데이비드 더블유. 라이트 변색된 멜라닌, 이의 제조 방법 및 이의 사용 방법
ES2027528A6 (es) 1990-12-17 1992-06-01 Andromaco Lab Procedimiento para la obtencion de polimeros con actividad antiviral.
US5744125A (en) 1993-08-19 1998-04-28 Yale University Cosmetic melanins
US6300057B1 (en) * 1997-02-06 2001-10-09 Large Scale Biology Corporation Melanins with improved ability to inhibit HIV replication

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5529909A (en) * 1988-02-26 1996-06-25 Biosource Technologies, Inc. Tyrosinase-activator protein fusion enzyme
WO1990012869A1 (en) * 1989-04-26 1990-11-01 Sloan-Kettering Institute For Cancer Research Non-melanocytic, eucaryotic cell constitutively expressing biologically active human tyrosinase and use thereof
WO1992000373A1 (en) * 1990-06-29 1992-01-09 Biosource Genetics Corporation Melanin production by transformed microorganisms
WO1992016189A1 (en) * 1990-10-25 1992-10-01 Yale University Soluble melanin
US5340734A (en) * 1992-11-25 1994-08-23 Biosource Genetics Corporation Method for making stable, extracellular tyrosinase and synthesis of polyphenolic polymers therefrom
US5466592A (en) * 1992-11-25 1995-11-14 Biosource Technologies, Inc. Method for making stable, extracellular tyrosinase and synthesis of polyphenolic polymers therefrom
US5486351A (en) * 1992-11-25 1996-01-23 Biosource Technologies, Inc. Method for making stable, extracellular tyrosinase and synthesis of polyphenolic polymers therefrom

Also Published As

Publication number Publication date
EP1095652A2 (de) 2001-05-02
ZA98975B (en) 1998-10-08
KR20000070851A (ko) 2000-11-25
US20020039726A1 (en) 2002-04-04
JP2001512437A (ja) 2001-08-21
CA2280178A1 (en) 1998-08-13
EP1096021A2 (de) 2001-05-02
AU6261698A (en) 1998-08-26
EP1095652A3 (de) 2004-03-03
AU730073B2 (en) 2001-02-22
EP1014964A1 (de) 2000-07-05
WO1998034606A1 (en) 1998-08-13
IL131233A0 (en) 2001-01-28
US6300057B1 (en) 2001-10-09
US6440691B1 (en) 2002-08-27

Similar Documents

Publication Publication Date Title
WO2003000200A3 (en) β-2'-OR 3'-HALONUCLEOSIDES
EP1163902A3 (de) Einen hydrophilen oder als Salz vorliegenden Arzneiwirkstoff enthaltende transdermale Zubereitung
DE60001914D1 (de) Mehrzweck zusammensetzungen von säuren
ATE383424T1 (de) Polypeptide, deren herstellung und verwendung
BR9908273A (pt) Formulações
BR0009480A (pt) Soluções de poliuretano com unidades de estrutura de alcoxissilano
MXPA01007710A (es) Agente de secado por congelacion que contiene paramilon, su produccion y uso.
BR0314354A (pt) Formação para gentes lipofìlicos
TR200101400T2 (tr) 2-Fenilbenzimidazoller ve 2-fenilindoller, hazırlanmaları ve kullanımları
WO2001058412A3 (de) Extrakte von rückständen aus der weinherstellung
TR200200068T2 (tr) Nematisital triflüorobütenler
CA2333601A1 (en) Surfactant for use in external preparations for skin and external preparation for skin containing the same
EP1790728A3 (de) Bildgebende Verfahren, Diagnose und Behandlung von Krankheiten
GB9902555D0 (en) Medicament
DE50004443D1 (de) Wirkstoffhaltige komposition sowie deren herstellung und verwendung
ATE264617T1 (de) Tissueprodukte mit antiviralen eigenschaften
AU2001287850A1 (en) Iron compositions
EP1095652A3 (de) Melanine mit verbesserten HIV replikationshemmenden Eigenschaften
WO2001078682A3 (en) Sustained release drug compositions
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
BR0013221A (pt) Chá preto de folha
WO1999051256A3 (en) Use of l-glu-l-trp in the treatment of hiv infection
WO2000072833A3 (de) Pharmazeutische zubereitungen zur hemmung von spimgomyelinase
BR9810556A (pt) Beta-alcoxiacrilatos contra a malária

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010201

AC Divisional application: reference to earlier application

Ref document number: 1014964

Country of ref document: EP

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: LARGE SCALE BIOLOGY CORPORATION

RIN1 Information on inventor provided before grant (corrected)

Inventor name: NEIDLEMAN, SAUL L.

Inventor name: GARGER, STEPHEN J., JR.

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

18D Application deemed to be withdrawn

Effective date: 20030902